TriSalus Life Sciences, Inc. TLSI Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s operating lease right-of-use asset amortization?
- TriSalus Life Sciences, Inc. (TLSI) reported operating lease right-of-use asset amortization of $31K in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- TriSalus Life Sciences, Inc.'s operating lease right-of-use asset amortization decreased by 82.1% year-over-year, from $173K to $31K.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s operating lease right-of-use asset amortization?
- Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s operating lease right-of-use asset amortization has grown at a 45.7% compound annual growth rate (CAGR), from $202K to $429K.